Welcome subscribers,
Life sciences facilities and data centres share notable similarities, requiring specialised expertise, intensive resources, and AI-driven growth—making them complex yet attractive real estate investments. This week, we compare these market segments alongside key updates on new buildings and leases across the UK and Europe:
✅ UK: 42 Technology leases Cambridge space
🔒 France: Roussy builds cancer research facility
🔒 Germany: Medisca leases Leipzig-Airport space
🔒 Ireland: women's health centre planned
(🔒 for paying members only)
Read more below for all the details.
— Stephen Ryan (connect with me on LinkedIn)
The overlooked similarities between life sciences facilities and data centres
As AI reshapes both biotech and cloud computing, investors are increasingly drawn to these surprisingly similar classes of assets.
🎯 Would you like to reach over 300 investors, developers, brokers and service providers in the life sciences real estate industry? You can now advertise in our weekly newsletter and deliver your message to our readers. Contact me if you are interested.
Transactions
GERMANY LEIPZIG
In Q1 2025, VGP fully leased the first hall of the new 45-hectare development phase at the "VGP Park Leipzig-Airport." Hall B is set for completion in the spring. One tenant, Medisca, a provider of personalised medicine solutions and pharmaceutical supply chain services, will take 5,000 sq m for production, storage, and office use. The main tenant will be the logistics company De Boer Logistics.
GERMANY MUNICH
BioNxt Solutions Inc., a Canadian bioscience company specialising in advanced drug delivery systems, is relocating its R&D operations to the Gen-Plus Laboratory in Munich, Germany, starting March 1, 2025. The move gives the company access to a 1,000 sq m facility specialised in high-potency pharmaceutical development and GMP-compliant processes. The new location will accelerate BioNxt's development of drug delivery systems, including sublingual thin films and transdermal patches, while enabling closer collaboration with leading European research institutions and biotech firms.
UK CAMBRIDGE
Life Science REIT signed a new occupier at Cambourne Park Science & Technology campus in Cambridge. Product design and innovation consultant 42 Technology (42T) has agreed a 10-year lease for around 17,200 sq ft of space at Building 1020. 42T, which is upsizing from its existing premises elsewhere in Cambridgeshire, is paying a rent of £25.50 (€30.70) per sq ft. The company is taking vacant office space, which it intends to partially convert to laboratory space. Established in 1998, 42T’s expertise in life sciences spans diagnostics, laboratory products, cell and gene therapy, and pharma and bioprocessing.
